Galapagos N.V. Sponsored ADR

Direct answer

Galapagos N.V. Sponsored ADR is publicly traded on NASDAQ under the ticker LKFT.

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Can you invest in Galapagos N.V. Sponsored ADR?

Yes. Galapagos N.V. Sponsored ADR trades publicly on NASDAQ as LKFT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Galapagos N.V. Sponsored ADR

Detailed equity research is provided by MarketSnap.